Clinical trial PACIFIC R
First real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy - PACIFIC Real World, PACIFIC-R
Cancers | |
---|---|
Organ | Lung |
Trial status | Trial closed for recruitment |
Investigator | |
Trial type |
Prospective observational study
|
Phase | Trial phase 4 |
Academic trial | Non |
Sponsor | AstraZeneca |
BECT Identifier | B707201939523 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03798535 |
Inclusion criteria | Advanced, recurrent, ou unresecable |
Last update |